Great Lakes NeuroTechnologies awarded patent for Parkinson’s assessment technology

BioOhio-member Great Lakes NeuroTechnologies received a patent covering advances to the company’s wireless patient-worn motion sensors that assess tremor, bradykinesia, rigidity, and dyskinesias associated with diseases like Parkinson’s and essential tremor. The Kinesia and Kinesia HomeView technology platform is FDA approved and has applications for both in-clinic and home-based patient care, as well as telemedicine.

Great Lakes NeuroTechnologies President Joseph Giuffrida said the allowance of the Valley View-based company’s patent claims is a continuation of a commercialization path that began in 2003.

“This heightened intellectual property position builds on and protects our previous commercialization efforts and continued market growth,” he said.

“We have a broad range of patent applications in the pipeline and expect this to be the first of many to cover our innovative product base of movement disorder technologies,” said Executive Vice President Brian Kolkowski. He added that the company is planning international patent filings.

Get more details in the company’s press release.

Recent Posts

Blog Post Archive

Blog Post Categories

Search the Blog

Newsticker


BioOhio Member Mark BioOhio Member

Norwood Medical in Dayton planning $13.5M expansion, adding 50 jobs | Dayton Business Journal, September 17, 2014

Youngstown Business Incubator and TechColumbus 1st and 3rd university associated incubators in the world | UBI Index, September 16, 2014

Enable Injections featured in article on safer, simpler, smarter devices for drug delivery | Drug Development & Delivery, September 15, 2014

BioOhio takes 2014 Annual Conference “on the road” in series of three regional events | Business Wire, September 15, 2014

ABC’s of IND’s – ChanTest to Host Session at the Safety Pharmacology Society (SPS) Annual Meeting | PR Web, September 15, 2014

Nationwide Children’s Hospital discusses Enterovirus D68 | Nationwide Children's Hospital, September 12, 2014

Akebia Therapeutics (NASDAQ: AKBA) to ring the NASDAQ Stock Market Opening Bell | NASDAQ, September 11, 2014

$1M grant to Cincinnati Children’s intended to improve human growth and development around the world | CCHMC, September 10, 2014

Airway Therapeutics gets money to advance treatment for smallest and sickest babies | WCPO9 Cincinnati, September 10, 2014

Airway Therapeutics raises $4.6M in Series A financing | CincyTech, September 10, 2014

Airway Therapeutics announces $4.6M funding round | Cincinnati.com, September 10, 2014

Alkermes anti-addiction drug Vivitrol helping inmates at Barnstable County Correctional Facility (MA) | Boston Business Journal, September 8, 2014

Nationwide Children’s Hospital now home to the world’s largest Ronald McDonald House | Columbus Dispatch, September 8, 2014

Envision Pharmaceutical completes its acquisition of MedTrak Services (Kansas) | Herald Online, September 8, 2014

Ohio Capital Fund key player in state startup scene | Cincinnati.com, September 6, 2014

Navidea enters Lymphoseek development and commercialization agreement with Hainan Sinotau Pharmaceutical Co., Ltd. subsidiary in China | Navidea Pharmaceuticals, September 4, 2014

Ricerca Biosciences in discussions to be acquired | OutsourcingPharma.com, September 3, 2014

Meridian Bioscience signs agreement with Premier to offer its hospitals molecular diagnostic tests and instruments | Business Wire, September 3, 2014

Cleveland Functional Electrical Stimulation Center taking toy donations at Expo to help disabled children | WKYC3 NBC, September 2, 2014

Aerpio Therapeutics announces publication of preclinical data on AKB-9778 for common eye diseases | Business Wire, September 2, 2014